Title: Monografía 2 bronquiectasias, Author: SEPAR, Name: Monografía 2 bronquiectasias, Length: pages, Page: 76, Published: Title: Monografía 2 bronquiectasias, Author: SEPAR, Name: Monografía 2 bronquiectasias, Length: pages, Page: , Published: Title: Monografía 2 bronquiectasias, Author: SEPAR, Name: Monografía 2 bronquiectasias, Length: pages, Page: 54, Published:
Author: | Nigal Mular |
Country: | Belize |
Language: | English (Spanish) |
Genre: | Politics |
Published (Last): | 24 November 2004 |
Pages: | 131 |
PDF File Size: | 8.97 Mb |
ePub File Size: | 8.86 Mb |
ISBN: | 426-5-67492-908-5 |
Downloads: | 53183 |
Price: | Free* [*Free Regsitration Required] |
Uploader: | Akinokazahn |
Inhaled steroids for bronchiectasis. Firma de consentimiento informado. Chang AB, Bilton D. Bronquiectasiqs bronchiectasis severity index. Read this article in English. Systemic comorbidities in bronchiectasis.
Spanish Guidelines on Treatment of Bronchiectasis in Adults.
State of the art review: Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Soporte familiar o de cuidadores. Are you a health professional able to prescribe or dispense drugs?
Quality of Life bronchiectasis questionnaire. Esta entrega se ha dedicado al tratamiento de las BQ. Ha sido investigador principal de proyectos financiados brlnquiectasias Praxis, Zambon y Chiesi.
Hospital Universitario de la Princesa. Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Pathological findings of bronchiectases caused by ycobacterium avium intracellulare complex.
Normativa sobre el tratamiento de las bronquiectasias en el adulto | Archivos de Bronconeumología
Fisioterapia respiratoria convencional drenaje postural, clapping. Calidad de la evidencia baja. Calidad de la evidencia elevada 15— Staphylococcus aureus resistente a la meticilina; vo: Effect of azithromicin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: Placebo for 48 weeks in patients with non-cystic fibrosis bronchiectasis.
Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: Calidad de la evidencia moderada 9. Finalmente, la calidad de la evidencia y la fuerza de las recomendaciones se han establecido bdonquiectasias las directrices de la propuesta GRADE anexos 1 y 2.
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Tratamiento de la enfermedad de base.
Prevalence and factors associated with isolation of Aspergillus and Candida from beonquiectasias in patients with noncystic fibrosis bronchiectasis. A series of recommendations have been drawn up, based on an in-depth review of the evidence for treatment of the underlying etiology, the bronchial infection in its different forms of presentation using existing therapies, bronchial inflammation, and airflow obstruction.
A prospective cohort analysis. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.
En la tabla 9 se puede observar la cadencia de visitas y pruebas recomendadas a realizar.
Spanish Guidelines on Treatment of Bronchiectasis in Adults.
Enfermos no cumplidores, con problemas psicosociales o adictos a drogas. Pneumococcal vaccines for children and adults with bronchiectasis. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Bilateral bronchiectasis and bronchiolitis at thin-section CT: Chest physiotherapy techniques in bronchiectasis.
The bronchiectasis severity index. Bronquiectasoas guidelines are focused on the treatment of bronchiectasis from both a multidisciplinary perspective, including specialty areas and the different healthcare levels involved, and a multidimensional perspective, including a comprehensive overview of the specific aspects of the disease.
Unidad de Cuidados Intensivos. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.